Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid vs Verapamil in Peyronie's Disease
NCT05855070Unknown
- Sponsor
- Benha University
- Start
- May 2023
- Primary completion
- May 2024
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
Randomised, double-blind trial of hyaluronic acid in Peyronie's disease (2 arms), sponsored by Benha University. Primary endpoint: Penile curvature degree. Status: unknown.
02
Drugs
hyaluronic acid
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT05855070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855070.